News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
254,268 Results
Type
Article (6828)
Company Profile (20)
Press Release (247420)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (89118)
Career Advice (593)
Deals (16633)
Drug Delivery (9)
Drug Development (22864)
Employer Resources (43)
FDA (4408)
Job Trends (4776)
News (133666)
Policy (9109)
Tag
Academia (416)
Accelerated approval (2)
Adcomms (3)
Allergies (12)
Alliances (16657)
ALS (22)
Alzheimer's disease (350)
Antibody-drug conjugate (ADC) (15)
Approvals (4430)
Artificial intelligence (53)
Autoimmune disease (5)
Automation (3)
Bankruptcy (109)
Best Places to Work (3613)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (77)
Cancer (549)
Cardiovascular disease (29)
Career advice (506)
Career pathing (5)
CAR-T (37)
Cell therapy (115)
Cervical cancer (2)
Clinical research (19145)
Collaboration (208)
Compensation (173)
Complete response letters (4)
COVID-19 (533)
CRISPR (8)
C-suite (115)
Cystic fibrosis (18)
Data (655)
Depression (25)
Diabetes (57)
Diagnostics (2325)
Digital health (3)
Diversity, equity & inclusion (17)
Drug discovery (28)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (13)
Earnings (43306)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (41672)
Executive appointments (341)
FDA (4737)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (240)
Gene editing (18)
Generative AI (3)
Gene therapy (55)
GLP-1 (133)
Government (693)
Guidances (20)
Healthcare (5940)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (15)
Indications (6)
Infectious disease (553)
Inflammatory bowel disease (26)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (22)
Interviews (99)
IPO (8465)
IRA (3)
Job creations (1276)
Job search strategy (435)
Kidney cancer (7)
Labor market (7)
Layoffs (111)
Leadership (7)
Legal (2734)
Liver cancer (17)
Lung cancer (60)
Lymphoma (43)
Management (14)
Manufacturing (57)
MASH (28)
Medical device (4522)
Medtech (4524)
Mergers & acquisitions (8410)
Metabolic disorders (150)
Multiple sclerosis (12)
NASH (6)
Neurodegenerative disease (16)
Neuropsychiatric disorders (8)
Neuroscience (502)
NextGen: Class of 2025 (1948)
Non-profit (910)
Now hiring (3)
Obesity (68)
Opinion (42)
Ovarian cancer (17)
Pain (23)
Pancreatic cancer (20)
Parkinson's disease (36)
Partnered (8)
Patents (44)
Patient recruitment (37)
Peanut (7)
People (26840)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5523)
Phase II (8442)
Phase III (6674)
Pipeline (597)
Policy (12)
Postmarket research (756)
Preclinical (2235)
Press Release (67)
Prostate cancer (30)
Psychedelics (16)
Radiopharmaceuticals (121)
Rare diseases (83)
Real estate (2060)
Recruiting (13)
Regulatory (6156)
Reports (17)
Research institute (408)
Resumes & cover letters (74)
Rett syndrome (5)
RNA editing (1)
Schizophrenia (31)
Series A (33)
Series B (27)
Service/supplier (2)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (31)
Sponsored (5)
Startups (1163)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (5)
The Weekly (2)
Vaccines (68)
Venture capitalists (4)
Weight loss (31)
Women's health (1)
Worklife (4)
Date
Today (66)
Last 7 days (255)
Last 30 days (858)
Last 365 days (11818)
2025 (3756)
2024 (12980)
2023 (15253)
2022 (21293)
2021 (22651)
2020 (20415)
2019 (15122)
2018 (11597)
2017 (11278)
2016 (10384)
2015 (13601)
2014 (10677)
2013 (8581)
2012 (9344)
2011 (9662)
2010 (9480)
Location
Africa (217)
Alabama (14)
Alaska (3)
Arizona (66)
Arkansas (2)
Asia (12574)
Australia (1840)
California (2141)
Canada (1177)
China (82)
Colorado (99)
Connecticut (105)
Delaware (38)
Europe (27035)
Florida (341)
Georgia (45)
Idaho (29)
Illinois (127)
India (9)
Indiana (93)
Iowa (2)
Japan (83)
Kansas (63)
Kentucky (11)
Louisiana (5)
Maine (41)
Maryland (232)
Massachusetts (1716)
Michigan (105)
Minnesota (158)
Mississippi (1)
Missouri (26)
Montana (16)
Nebraska (15)
Nevada (28)
New Hampshire (24)
New Jersey (752)
New Mexico (8)
New York (583)
North Carolina (385)
North Dakota (3)
Northern California (1020)
Ohio (61)
Oklahoma (7)
Oregon (4)
Pennsylvania (452)
Puerto Rico (2)
Rhode Island (13)
South America (335)
South Carolina (5)
Southern California (767)
Tennessee (46)
Texas (290)
United States (8251)
Utah (67)
Virginia (49)
Washington D.C. (17)
Washington State (183)
West Virginia (2)
Wisconsin (35)
254,268 Results for "anx robotica corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
AnX Robotica Announces FDA Clearance for ProScan™: A Groundbreaking AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy
AnX Robotica, a pioneering force in advanced gastrointestinal visualization technologies, is excited to announce the FDA clearance of NaviCam ProScan™.
January 3, 2024
·
2 min read
Policy
AnX Robotica is Pleased to Announce FDA Clearance for Expanded Indications of NaviCam Small Bowel Video Capsule Endoscopy
AnX Robotica is thrilled to announce FDA clearance for expanded indications of its NaviCam Small Bowel Video Capsule Endoscopy in both adults and children aged 2 years and above.
January 15, 2024
·
2 min read
Lone Star Bio
AnX Robotica Commences Launch of the NaviCam® Small Bowel System
AnX Robotica Corporation (www.anxrobotics.com), the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE), is pleased to announce the launch of the NaviCam Small Bowel System in the United States.
February 6, 2023
·
1 min read
Business
AnX Robotica Partners with GastroGPO, a Specialty Networks Company
AnX Robotica Corporation, the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System, is pleased to announce a partnership with GastroGPO, a Specialty Networks Company.
December 7, 2022
·
2 min read
Press Releases
Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting
February 14, 2025
·
7 min read
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Drug Development
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting
Annexon, Inc. (Nasdaq: ANNX), today announced positive results from the completed pivotal Phase 3 trial of C1q-targeted immunotherapy, ANX005, in Guillain-Barré Syndrome (GBS) at the 2024 Peripheral Nerve Society (PNS) Annual Meeting in Montréal, Canada.
June 25, 2024
·
9 min read
Press Releases
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
December 6, 2024
·
9 min read
Press Releases
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
April 9, 2025
·
2 min read
Drug Development
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
Annexon, Inc. (Nasdaq: ANNX) today presented new analyses of ANX007 from the Phase 2 ARCHER trial in geographic atrophy (GA), and new preclinical data on the role of C1q in the pathogenic elimination of photoreceptor synapses and their protection with C1q blockade in GA.
May 7, 2024
·
11 min read
1 of 25,427
Next
